Exp Clin Endocrinol Diabetes 1996; 104: 52-53
DOI: 10.1055/s-0029-1211533
Part II — Oral Presentations
Postreceptor Signalling II
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

O-42: Mitogenic signalling by insulin in a T-cell lymphoma, the LB cell line, devoid of IGF-I receptors: evidence for the lack of involvement of the RAS-MAP kinase pathway and for a possibly novel IRS-like molecule

Birgitte Ursø1 , Claus T Christoffersen1 , Margriet Ouwens2 , Chris Vlahos3 , Hans Tornqvist1 , Morris White4 , David Naor5 , Pierre De Meyts1
  • 1Hagedorn Research Institute, Gentofte, Denmark
  • 2University of Leiden, Leiden, the Netherlands
  • 3Lilly Research Laboratories, Indianapolis, USA
  • 4Joslin Diabetes Center, Boston, USA
  • 5The Lautenberg Center for General and Tumor Immunology, Hadassah Medical School, Jerusalem, Israel
Further Information

Publication History

Publication Date:
15 July 2009 (online)